By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Today in CanadaToday in CanadaToday in Canada
Notification Show More
Font ResizerAa
  • Home
  • News
  • Lifestyle
  • Things To Do
  • Entertainment
  • Health
  • Tech
  • Travel
  • Press Release
  • Spotlight
Reading: Bankrupt DNA testing company 23andMe to be bought by Regeneron
Share
Today in CanadaToday in Canada
Font ResizerAa
  • News
  • Things To Do
  • Lifestyle
  • Entertainment
  • Health
  • Travel
Search
  • Home
  • News
  • Lifestyle
  • Things To Do
  • Entertainment
  • Health
  • Tech
  • Travel
  • Press Release
  • Spotlight
Have an existing account? Sign In
Follow US
Today in Canada > Health > Bankrupt DNA testing company 23andMe to be bought by Regeneron
Health

Bankrupt DNA testing company 23andMe to be bought by Regeneron

Press Room
Last updated: 2025/05/19 at 9:13 AM
Press Room Published May 19, 2025
Share
SHARE

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million USD through a bankruptcy auction, the companies said on Monday.

Regeneron said it will comply with 23andMe’s privacy policies and applicable laws with respect to the use of customer  data and that it is ready to detail its intended use of the data to a court-appointed overseer.

The bankruptcy proceedings, filed in March, had drawn scrutiny from lawmakers who warned that millions of customers’ genetic data could be sold to unscrupulous buyers.

23andMe last month agreed to allow a court-appointed overseer for the company’s handling of customers’ genetic information and its security policies during the bankruptcy.

The company has collected genetic data from 15 million customers who ordered its DNA testing kits online and provided saliva samples.

The company had been struggling with weak demand for its ancestry testing kits and a data breach in 2023 that exposed millions of customers’ genetic data.

As part of the agreement, Regeneron will acquire all units of 23andMe, except telehealth service Lemonaid Health, which the genetic testing firm plans to wind down.

After the transaction completes, 23andMe will continue to operate as a wholly owned direct or indirect unit of Regeneron, the companies said.

The companies expect to close the deal in the third quarter of this year. 

Quick Link

  • Stars
  • Screen
  • Culture
  • Media
  • Videos
Share This Article
Facebook Twitter Email Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

You Might Also Like

Health

This nurse visited Nanaimo with hundreds of other Americans. Now she wants to relocate there

May 19, 2025
Health

Vaccine skepticism a growing concern, virologist warns amid rising measles caseload

May 18, 2025
Health

Cannabis can be used as a psychedelic in therapy, but it’s not for everyone, some mental health providers say

May 17, 2025
Health

I never imagined my 4th pregnancy would be my first without a family doctor

May 17, 2025
© 2023 Today in Canada. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Advertise
  • Contact
Welcome Back!

Sign in to your account

Lost your password?